Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3628025 | 0.64 | ALDH1A1 (0.35) | KMT2A | |
| SCHEMBL11362806 | 0.61 | MAPK1 (0.35) | — | |
| SCHEMBL25255933 | 0.56 | ALDH1A1 (0.44) | — | |
| Hydrochloric Acid SCHEMBL9786969 | 0.54 | BLM (0.31) | — | |
| SCHEMBL11884214 | 0.53 | MEN1 (0.33) | KMT2A | |
| SCHEMBL23733143 | 0.51 | LMNA (0.34) | KMT2A | |
| Acetic Acid SCHEMBL96751 | 0.44 | — | — | |
| Acetic Acid SCHEMBL30765430 | 0.44 | — | — | |
| Acetic Acid SCHEMBL7007795 | 0.44 | FFAR3 (0.88) | — | |
| Acetic Acid SCHEMBL7947408 | 0.44 | FFAR3 (0.88) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240026340-A1 | BLOOD COLLECTION DEVICE FOR IMPROVED NUCLEIC ACID REGULATION | STRECK LLC (US) | 2024-01-25 | — | — | US | claimed |
| EP-3789499-B1 | BLOOD COLLECTION DEVICE FOR IMPROVED NUCLEIC ACID REGULATION | STRECK INC (US) | 2023-03-15 | — | — | EP | claimed |
| EP-3946054-A1 | COMPOSITIONS, METHODS AND SYSTEMS FOR PROTEIN CORONA ANALYSIS FROM BIOFLUIDS AND USES THEREOF | Seer, Inc. (US) | 2022-02-09 | — | — | EP | claimed |
| US-20210310071-A1 | URINARY MICROBIOMIC PROFILING | Convergent Genomics, Inc. | 2021-10-07 | — | — | US | claimed |
| US-20210215709-A1 | COMPOSITIONS, METHODS AND SYSTEMS FOR PROTEIN CORONA ANALYSIS FROM BIOFLUIDS AND USES THEREOF | SEER, INC. | 2021-07-15 | — | — | US | claimed |
| EP-2814981-B2 | BLOOD COLLECTION METHOD FOR STABILIZING CELL-FREE PLASMA DNA | STRECK INC (US) | 2021-04-28 | — | — | EP | claimed |
| EP-3789499-A1 | BLOOD COLLECTION DEVICE FOR IMPROVED NUCLEIC ACID REGULATION | Streck, Inc. (US) | 2021-03-10 | — | — | EP | claimed |
| WO-2020198209-A1 | COMPOSITIONS, METHODS AND SYSTEMS FOR PROTEIN CORONA ANALYSIS FROM BIOFLUIDS AND USES THEREOF | SEER, INC. (US) | 2020-10-01 | — | — | WO | claimed |
| EP-3225699-B1 | BLOOD COLLECTION DEVICE FOR IMPROVED NUCLEIC ACID REGULATION | STRECK INC (US) | 2020-09-30 | — | — | EP | claimed |
| US-20200255819-A1 | BLOOD COLLECTION DEVICE FOR IMPROVED NUCLEIC ACID REGULATION | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2020-08-13 | — | — | US | claimed |
| EP-2888354-B1 | VIRUS PARTICLE STABILISATION AND METHOD FOR ISOLATING VIRAL NUCLEIC ACIDS | QIAGEN GMBH (DE) | 2020-04-01 | — | — | EP | claimed |
| EP-2888363-B1 | METHOD FOR ISOLATING NUCLEIC ACIDS FROM A FORMALDEHYDE RELEASER STABILIZED SAMPLE | QIAGEN GMBH (DE) | 2018-06-06 | — | — | EP | claimed |
| EP-2814981-B1 | BLOOD COLLECTION DEVICE FOR STABILIZING CELL-FREE PLASMA DNA | STRECK INC (US) | 2017-06-28 | — | — | EP | claimed |
| US-20140080112-A1 | BLOOD COLLECTION DEVICE FOR IMPROVED NUCLEIC ACID REGULATION | STRECK, INC. | 2014-03-20 | — | — | US | claimed |
| US-20100209930-A1 | PRESERVATION OF CELL-FREE NUCLEIC ACIDS | STRECK, INC. (US) | 2010-08-19 | — | — | US | claimed |
| US-20100184069-A1 | PRESERVATION OF FETAL NUCLEIC ACIDS IN MATERNAL PLASMA | STRECK, INC. (US) | 2010-07-22 | — | — | US | claimed |
| US-20100167271-A1 | METHOD FOR SCREENING BLOOD USING A PRESERVATIVE THAT MAY BE IN A SUBSTANTIALLY SOLID STATE FORM | STRECK, INC. (US) | 2010-07-01 | — | — | US | claimed |
| EP-1816461-A1 | Method and device for collecting and preserving cells for analysis | Streck Laboratories, Inc. (US) | 2007-08-08 | — | — | EP | claimed |
| EP-1413874-A1 | Method and device for collecting and preserving cells for analysis | Streck Laboratories, Inc. (US) | 2004-04-28 | — | — | EP | claimed |
| US-20240026340-A1 | BLOOD COLLECTION DEVICE FOR IMPROVED NUCLEIC ACID REGULATION | STRECK LLC (US) | 2024-01-25 | — | — | US | disclosed |
| WO-2023228174-A9 | USEFUL COMBINATIONS OF RESTRICTION ENZYMES | NUCLEIX LTD. (IL) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023227954-A1 | SAMPLE PREPARATION FOR CELL-FREE DNA ANALYSIS | NUCLEIX LTD. (IL) | 2023-11-30 | — | — | WO | disclosed |
| US-11746372-B2 | Rapid nucleic acids separation and sample preparation via hollow-centered silica microsphere | GODX, INC. (US) | 2023-09-05 | — | — | US | disclosed |
| WO-2023154967-A2 | DIAGNOSIS OF COLORECTAL CANCER USING TARGETED QUANTIFICATION OF SITE-SPECIFIC PROTEIN GLYCOSYLATION | VENN BIOSCIENCES CORPORATION (US) | 2023-08-17 | — | — | WO | disclosed |
| WO-2023135487-A2 | METHOD FOR ANALYZING BLOOD STORED FOR LATER ANALYSIS OF CELL FREE DNA | LITTLE STEPHEN (GB) | 2023-07-20 | — | — | WO | disclosed |
| US-20230180742-A1 | Compositions and Methods for Stabilizing Circulating Tumor Cells | STRECK LLC | 2023-06-15 | — | — | US | disclosed |
| US-20230160881-A1 | HMGB1 RNA And Methods Therefor | NANTOMICS LLC (US) | 2023-05-25 | — | — | US | disclosed |
| WO-2023089613-A1 | WHOLE GENOME CPG ANALYSIS | NUCLEIX LTD. (IL) | 2023-05-25 | — | — | WO | disclosed |
| US-11647743-B2 | Method and device for collecting and preserving cells for analysis | STRECK LLC (US) | 2023-05-16 | — | — | US | disclosed |
| US-11634747-B2 | Preservation of fetal nucleic acids in maternal plasma | STRECK LLC (US) | 2023-04-25 | — | — | US | disclosed |
| EP-3789499-B1 | BLOOD COLLECTION DEVICE FOR IMPROVED NUCLEIC ACID REGULATION | STRECK INC (US) | 2023-03-15 | — | — | EP | disclosed |
| US-20230076807-A1 | COMPOSITIONS, METHODS AND SYSTEMS FOR PROTEIN CORONA ANALYSIS AND USES THEREOF | SEER, INC. | 2023-03-09 | — | — | US | disclosed |
| EP-4136972-A1 | COMPOSITIONS AND METHODS FOR STABILIZING CIRCULATING TUMOR CELLS | Streck, Inc. (US) | 2023-02-22 | — | — | EP | disclosed |
| US-11547111-B2 | Compositions and methods for stabilizing circulating tumor cells | STRECK, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| EP-3946054-A1 | COMPOSITIONS, METHODS AND SYSTEMS FOR PROTEIN CORONA ANALYSIS FROM BIOFLUIDS AND USES THEREOF | Seer, Inc. (US) | 2022-02-09 | — | — | EP | disclosed |
| US-20210215709-A1 | COMPOSITIONS, METHODS AND SYSTEMS FOR PROTEIN CORONA ANALYSIS FROM BIOFLUIDS AND USES THEREOF | SEER, INC. | 2021-07-15 | — | — | US | disclosed |
| US-20210180108-A1 | RAPID NUCLEIC ACIDS SEPARATION AND SAMPLE PREPARATION VIA HOLLOW-CENTERED SILICA MICROSPHERE | GODX, INC (US) | 2021-06-17 | — | — | US | disclosed |
| EP-2814981-B2 | BLOOD COLLECTION METHOD FOR STABILIZING CELL-FREE PLASMA DNA | STRECK INC (US) | 2021-04-28 | — | — | EP | disclosed |
| US-10966421-B2 | Method and device for collecting and preserving cells for analysis | STRECK, INC. (US) | 2021-04-06 | — | — | US | disclosed |
| EP-3789499-A1 | BLOOD COLLECTION DEVICE FOR IMPROVED NUCLEIC ACID REGULATION | Streck, Inc. (US) | 2021-03-10 | — | — | EP | disclosed |
| US-20200377955-A1 | USE OF CELL-FREE CIRCULATING RNA (cfRNA) EXPRESSION OF PD-L1 AND ERCC1 IN PLASMA TO MONITOR RESPONSE TO THERAPY IN NSCLC | NANTHEALTH LABS, INC. | 2020-12-03 | — | — | US | disclosed |
| US-20200315163-A1 | Compositions and Methods for Stabilizing Circulating Tumor Cells | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2020-10-08 | — | — | US | disclosed |
| WO-2020198209-A1 | COMPOSITIONS, METHODS AND SYSTEMS FOR PROTEIN CORONA ANALYSIS FROM BIOFLUIDS AND USES THEREOF | SEER, INC. (US) | 2020-10-01 | — | — | WO | disclosed |
| EP-3225699-B1 | BLOOD COLLECTION DEVICE FOR IMPROVED NUCLEIC ACID REGULATION | STRECK INC (US) | 2020-09-30 | — | — | EP | disclosed |
| US-20200255819-A1 | BLOOD COLLECTION DEVICE FOR IMPROVED NUCLEIC ACID REGULATION | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2020-08-13 | — | — | US | disclosed |
| US-20200248267-A1 | TUMOR VS. MATCHED NORMAL cfRNA | NANTOMICS LLC (US) | 2020-08-06 | — | — | US | disclosed |
| US-10674721-B2 | Compositions and methods for stabilizing circulating tumor cells | STRECK, INC. (US) | 2020-06-09 | — | — | US | disclosed |
| US-20200165685-A1 | CIRCULATING RNA FOR DETECTION, PREDICTION, AND MONITORING OF CANCER | NANTOMICS, LLC | 2020-05-28 | — | — | US | disclosed |
| EP-3642351-A1 | USE OF CELL-FREE CIRCULATING RNA (cfRNA) EXPRESSION OF PD-L1 AND ERCC1 IN PLASMA TO MONITOR RESPONSE TO THERAPY IN NSCLC | Nantomics, LLC (US) | 2020-04-29 | — | — | EP | disclosed |
| EP-3628057-A2 | TUMOR VS. MATCHED NORMAL cfRNA | Nantomics, LLC (US) | 2020-04-01 | — | — | EP | disclosed |
| EP-3622071-A1 | CIRCULATING RNA FOR DETECTION, PREDICTION, AND MONITORING OF CANCER | Nantomics, LLC (US) | 2020-03-18 | — | — | EP | disclosed |
| US-20190300948-A1 | METHODS FOR IDENTIFICATION OF SAMPLES | DNAME-IT NV (BE) | 2019-10-03 | — | — | US | disclosed |
| WO-2019183263-A1 | INSTRUMENTATION-FREE PAPER ORIGAMIRAPID MOLECULAR DIAGNOSTIC DEVICE | GODX, INC. (US) | 2019-09-26 | — | — | WO | disclosed |
| EP-3458606-A1 | METHODS FOR IDENTIFICATION OF SAMPLES | DName-iT NV (BE) | 2019-03-27 | — | — | EP | disclosed |
| WO-2019055851-A1 | HMGB1 RNA AND METHODS THEREFOR | NANTOMICS, LLC (US) | 2019-03-21 | — | — | WO | disclosed |
| US-20190075785-A1 | Compositions and Methods for Stabilizing Circulating Tumor Cells | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2019-03-14 | — | — | US | disclosed |
| WO-2018236811-A1 | USE OF CELL-FREE CIRCULATING RNA (cfRNA) EXPRESSION OF PD-L1 AND ERCC1 IN PLASMA TO MONITOR RESPONSE TO THERAPY IN NSCLC | NANTCELL, INC. (US) | 2018-12-27 | — | — | WO | disclosed |
| WO-2018208892-A1 | CIRCULATING RNA FOR DETECTION, PREDICTION, AND MONITORING OF CANCER | NANTOMICS, LLC (US) | 2018-11-15 | — | — | WO | disclosed |
| WO-2018204377-A2 | TUMOR VS. MATCHED NORMAL cfRNA | NANTOMICS, LLC (US) | 2018-11-08 | — | — | WO | disclosed |
| US-10091984-B2 | Compositions and methods for stabilizing circulating tumor cells | STRECK, INC. (US) | 2018-10-09 | — | — | US | disclosed |
| WO-2018145005-A1 | SAMPLE COLLECTION TUBE WITH PRESERVATIVE | STRECK, INC. (US) | 2018-08-09 | — | — | WO | disclosed |
| WO-2017198742-A1 | METHODS FOR IDENTIFICATION OF SAMPLES | DNAME-IT NV (BE) | 2017-11-23 | — | — | WO | disclosed |
| EP-3246412-A1 | METHODS FOR IDENTIFICATION OF SAMPLES | DName-iT NV (BE) | 2017-11-22 | — | — | EP | disclosed |
| EP-3225699-A1 | BLOOD COLLECTION DEVICE FOR IMPROVED NUCLEIC ACID REGULATION | Streck, Inc. (US) | 2017-10-04 | — | — | EP | disclosed |
| EP-2814981-B1 | BLOOD COLLECTION DEVICE FOR STABILIZING CELL-FREE PLASMA DNA | STRECK INC (US) | 2017-06-28 | — | — | EP | disclosed |
| US-9657227-B2 | Preservation of cell-free RNA in blood samples | STRECK, INC. (US) | 2017-05-23 | — | — | US | disclosed |
| US-20160174544-A1 | Compositions and Methods for Stabilizing Circulating Tumor Cells | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2016-06-23 | — | — | US | disclosed |
| US-20160143268-A1 | METHOD AND DEVICE FOR COLLECTING AND PRESERVING CELLS FOR ANALYSIS | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2016-05-26 | — | — | US | disclosed |
| US-20140080112-A1 | BLOOD COLLECTION DEVICE FOR IMPROVED NUCLEIC ACID REGULATION | STRECK, INC. | 2014-03-20 | — | — | US | disclosed |
| US-20140054508-A1 | PRESERVATION OF CELL-FREE RNA IN BLOOD SAMPLES | STRECK, INC. (US) | 2014-02-27 | — | — | US | disclosed |
| US-8304187-B2 | Preservation of cell-free RNA in blood samples | STRECK, INC. (US) | 2012-11-06 | — | — | US | disclosed |
| US-20110300608-A1 | NUCLEIC ACID ISOLATION IN PRESERVED WHOLE BLOOD | STRECK, INC. (US) | 2011-12-08 | — | — | US | disclosed |
| US-20110111410-A1 | STABILIZATION OF RNA IN INTACT CELLS WITHIN A BLOOD SAMPLE | STRECK, INC. (US) | 2011-05-12 | — | — | US | disclosed |
| US-20100317107-A1 | METHOD AND DEVICE FOR COLLECTING AND PRESERVING CELLS FOR ANALYSIS | STRECK, INC. (US) | 2010-12-16 | — | — | US | disclosed |
| US-20100209930-A1 | PRESERVATION OF CELL-FREE NUCLEIC ACIDS | STRECK, INC. (US) | 2010-08-19 | — | — | US | disclosed |
| US-20100184069-A1 | PRESERVATION OF FETAL NUCLEIC ACIDS IN MATERNAL PLASMA | STRECK, INC. (US) | 2010-07-22 | — | — | US | disclosed |
| US-20100167271-A1 | METHOD FOR SCREENING BLOOD USING A PRESERVATIVE THAT MAY BE IN A SUBSTANTIALLY SOLID STATE FORM | STRECK, INC. (US) | 2010-07-01 | — | — | US | disclosed |
| EP-1816461-A1 | Method and device for collecting and preserving cells for analysis | Streck Laboratories, Inc. (US) | 2007-08-08 | — | — | EP | disclosed |
| US-20040137417-A1 | METHOD AND DEVICE FOR COLLECTING AND PRESERVING CELLS FOR ANALYSIS | STRECK LABORATORIES INC. (US) | 2004-07-15 | — | — | US | disclosed |
| EP-1413874-A1 | Method and device for collecting and preserving cells for analysis | Streck Laboratories, Inc. (US) | 2004-04-28 | — | — | EP | disclosed |
| EP-1413874-A1 | Method and device for collecting and preserving cells for analysis | Streck Laboratories, Inc. (US) | 2004-04-28 | — | — | EP | disclosed |